Anixa Biosciences Inc. Revenue 2010–2024
Anixa Biosciences Inc. annual/quarterly revenue history and growth rate from 2010 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Anixa Biosciences Inc. revenue for the quarter ending April 30, 2023 was 210000, a 16.00% decrease year-over-year.
- Anixa Biosciences Inc. revenue for the twelve months ending April 30, 2023 was 1.5 M, a 5.65% decrease year-over-year.
- Anixa Biosciences Inc. annual revenue for 2024 was 210000, a 0.00% increase from 2023.
- Anixa Biosciences Inc. annual revenue for 2023 was 210000, a 58.98% decrease from 2021.
- Anixa Biosciences Inc. annual revenue for 2021 was 512000, a 104.80% increase from 2019.
- Anixa Biosciences Inc. annual revenue for 2019 was 250000.
Anixa Biosciences Inc. (ANIX) — Frequently Asked Questions
Anixa Biosciences Inc. (ANIX) is a publicly traded US company. It has a market capitalization of $79,426.02. In fiscal 2024 it reported revenue of $210,000 and net income of -$13M. Explore ANIX's stock price, financial statements, earnings history, margins and key ratios below.
What is Anixa Biosciences Inc.'s market cap?
Anixa Biosciences Inc. (ANIX) has a market capitalization of $79,426.02.
What is the ANIX stock price?
ANIX trades at $2.49 (+5.96% on the day).
How much revenue does Anixa Biosciences Inc. make?
Anixa Biosciences Inc. reported revenue of $210,000 in fiscal 2024.
Is ANIX profitable?
In fiscal 2024, Anixa Biosciences Inc. reported net income of -$13M.